$INO Why would the CFO and the Chief Scientific Officer sell going into a phase 3 clinical trial.....hmmmm Form 4 INOVIO PHARMACEUTICALS, For: Jul 15 Filed by: KIES PETER US Securities and Exchange Commission - 7:00 PM ET, 07/17/2020 Filed on: July 17, 2020. Form 4 INOVIO PHARMACEUTICALS, For: Jun 30 Filed by: KIES PETER US Securities and Exchange Commission - 9:19 PM ET, 07/02/2020 Filed on: July 2, 2020. Form 4 INOVIO PHARMACEUTICALS, For: Jun 30 Filed by: KIES PETER US Securities and Exchange Commission - 9:19 PM ET, 07/02/2020 Filed on: July 2, 2020.